Additional file 7: Table S4. of Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
收藏DataCite Commons2024-12-18 更新2024-07-25 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_7_Table_S4_of_Axitinib_and_sorafenib_are_potent_in_tyrosine_kinase_inhibitor_resistant_chronic_myeloid_leukemia_cells/4377584/1
下载链接
链接失效反馈官方服务：
资源简介：
Anti-GAB2 IP of Imatinib, Axitinib and Sorafenib vs DMSO treated cells. SILAC ratios are normalized to GAB2. Only sites with localization probabilities greater 0.75 and Andromeda scores greater 40 are shown. PEP: posterior error probability. (XLSX 12 kb)
提供机构：
Figshare
创建时间：
2017-12-19
